The advanced business and scientific vision of its founders has unabled GENFIT to become a world-renowned company based on solid industrial foundations combining innovation, market adaptation, productivity and cost management.
Combining scientific innovation and cost-efficient pragmatism
In the late 1990s, the co-founders of GENFIT recognized the potential of building a biotechnology company in the heart of the Eurasanté technology park at Lille. This dedicated biohealth-related hub located at the crossroads of Europe, today boasts over 650 companies and more than 2000 scientists. Thanks to its subsidiary, Genfit Corp., situated in Cambridge, MA, GENFIT also benefits from a strategic location in the USA.
GENFIT’s deep-rooted entrepreneurial spirit and advanced scientific capabilities correspond perfectly to the pharmaceutical industry’s needs for a combination of research and managerial excellence, clinical know-how, and cutting-edge technologies. Its strategic alliances with multiple pharmaceutical partners have enabled GENFIT to launch original research programs, and to develop a rich and diversified pipeline of drug candidates, both proprietary and in partnership with leading pharmaceutical companies.
